Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Banks

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Oncology Reports|August 13, 2013
Plasma osteopontin concentrations in patients with cutaneous melanomaA Filia, F Elliott, T Wind, et al.
British Journal of Cancer|July 2, 1999
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancerA S Protheroe, R E Banks, M Mzimba, et al.
Cytokine|September 1, 1996
Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral bloodD Clarke, P W Johnson, R E Banks, et al.
Oncogene|December 7, 2010
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinomaM R Morris, C J Ricketts, D Gentle, et al.
British Journal of Cancer|June 2, 2005
Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinomaJ J Ord, E Streeter, A Jones, et al.
Oncogene|September 27, 2006
Identification of novel VHL targets that are associated with the development of renal cell carcinomaM Abdulrahman, E N Maina, M R Morris, et al.
British Journal of Cancer|January 1, 1997
Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokinesR E Banks, M A Forbes, S Hallam, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2008
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancerP M Patel, S Sim, D O O'Donnell, et al.
Molecular Human Reproduction|June 10, 1998
Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1R E Banks, M A Forbes, J Searles, et al.
Cytokine|May 11, 2000
Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effectsR E Banks, M A Forbes, P M Patel, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Oncology Reports|August 13, 2013
Plasma osteopontin concentrations in patients with cutaneous melanomaA Filia, F Elliott, T Wind, et al.
British Journal of Cancer|July 2, 1999
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancerA S Protheroe, R E Banks, M Mzimba, et al.
Cytokine|September 1, 1996
Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral bloodD Clarke, P W Johnson, R E Banks, et al.
Oncogene|December 7, 2010
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinomaM R Morris, C J Ricketts, D Gentle, et al.
British Journal of Cancer|June 2, 2005
Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinomaJ J Ord, E Streeter, A Jones, et al.
Oncogene|September 27, 2006
Identification of novel VHL targets that are associated with the development of renal cell carcinomaM Abdulrahman, E N Maina, M R Morris, et al.
British Journal of Cancer|January 1, 1997
Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokinesR E Banks, M A Forbes, S Hallam, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2008
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancerP M Patel, S Sim, D O O'Donnell, et al.
Molecular Human Reproduction|June 10, 1998
Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1R E Banks, M A Forbes, J Searles, et al.
Cytokine|May 11, 2000
Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effectsR E Banks, M A Forbes, P M Patel, et al.
Pageof 8